Wilson Sonsini Goodrich & Rosati advised Iambic Therapeutics on the transaction. Iambic Therapeutics (Iambic), a clinical-stage biotechnology company, announced the closing of an oversubscribed $50 million...
Iambic Therapeutics’ $50 Million Series B Extension Financing
Reunion Neuroscience’s $103 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A...
ArteraAI’s $20 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised ArteraAI on the transaction. ArteraAI announced it has secured an additional $20 million in capital fueled by several prominent large...
Renesas’ $339 Million Acquisition of Transphorm
Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
MapLight Therapeutics’ $225 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
Leap’s $12 Million Funding Round
Wilson Sonsini Goodrich & Rosati represented Leap in the transaction. Leap announced it has secured a new capital raise totaling $12 million in equity financing. The funding...
Coloplast’s $1.3 Billion Acquisition of Kerecis
Wilson Sonsini Goodrich & Rosati represented Kerecis on the transaction, while LOGOS Legal Services advised Kerecis on Icelandic law matters. Coloplast announced it has signed an agreement...
Via’s Acquisition of MPEG LA
Wilson Sonsini Goodrich & Rosati advised Via on the deal. collaborative licensing leader Via Licensing Corporation (Via) announced its acquisition of MPEG LA forming Via Licensing...
Nextracker’s Initial Public Offering
Wilson Sonsini represented underwriters on the deal while Sidley represented Flex Ltd. and Nextracker Inc. Flex Ltd. announced that its subsidiary, Nextracker Inc., priced its upsized...
Paddle’s $200 Million Series D Financing
Wilson Sonsini Goodrich & Rosati advised Paddle on the deal. Willkie Farr & Gallagher advised FTV Capital, 83North, Notion Capital and Kindred Capital. Gibson, Dunn &...
Cognism’s $87.5 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Cognism on the deal. Cognism, the globally compliant international sales intelligence provider announced it has secured $87.5 million in funding...
BIOMILQ, Inc.’s $21 Million Series A Financing
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the deal. North Carolina-based mammary biotechnology company BIOMILQ, Inc., announced the successful close of $21 million in...